Such experiments, coupled with single cell/single nucleus transcriptomic studies, may distinguish the effects of DIAPH1 in vascular cells, immune cells or hepatocytes and their cross-talk on lipid metabolism, inflammation and atherosclerosis. Here, DIAPH1 is linked to atherosclerosis.